EP386 TOPICAL TREATMENT OF TECHNOLOGY LIPIDO-COLLOID WITH NANO-OLIGO-SACCHARIDE FACTOR WOUND DRESSING (TLC-NOFS) OF DIABETIC FOOT ULCER.

Aim: The aim of the following paper strives at assessing the efficiency of the application of the TLC-NOSF (Technology Lipido- Colloid with Nano-Oligo-Saccharide Factor) wound dressings in patients with diabetic foot ulcer. Method: 40 patients with DFU of grade I and II (Wagner's classification) were selected for the study and randomized into two groups. The first group consisted of 20 patients (ulceration area: 4.5-7.1 cm2) who were treated by TLC-NOSF dressing, UrgoStart®, Poland). The second group comprised 20 patients (ulceration area 4,3-6,7 cm2) treated by silver foam dressing -- Biatain Ag Adhesive Foam Coloplast, Poland). All dressings were changed every two days until the wound was thoroughly healed. The changes in the wound area, which occurred every week, were calculated. Additionally, the pace of the healing process was also measured every day -- healing per day index (cm2/day). Results / Discussion: The results reveal that after five weeks of treatment, the ulcers healed in all patients, who belonged to the first group. Whereas, in the case of the second group, the ulcers healed after eight weeks of the treatment. Conclusion: Basing the analysis on the observations, the authors unanimously state that the application of Technology Lipido- Colloid with Nano-Oligo-Saccharide Factor wound dressing (TLC-NOFS), significantly contributes to the process of treating diabetic foot ulceration. [ABSTRACT FROM AUTHOR]